Physician profile
Carlene Wolfe
NPI 1518052661
$676.22
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $416 · 2023: $246 · 2024: $13.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $129.11 | 2022-2024 | Xifaxan, Plenvu, Trulance |
| Genzyme Corporation | $101.09 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $101.01 | 2022-2023 | Gattex, Entyvio |
| Abbvie INC. | $62.58 | 2022-2023 | |
| Qol Medical, LLC | $60.14 | 2022 | |
| Daiichi Sankyo INC. | $46.19 | 2022 | |
| Intra-Sana Laboratories | $35.76 | 2022-2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Intercept Pharmaceuticals, INC. | $31.48 | 2022 | |
| Janssen Biotech, INC. | $21.24 | 2023 | Stelara |
| Regeneron Healthcare Solutions, INC. | $19.38 | 2023 | Dupixent |
| Merck Sharp & Dohme LLC | $19.33 | 2023 | Dificid |
| Ardelyx, INC. | $19.28 | 2023 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $15.72 | 2023 | Linzess |
| Nestle Healthcare Nutrition INC. | $13.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlene Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.